Compare Nuwellis Inc (NUWE) vs Quantum Computing Inc (QUBT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Quantum Computing Inc — how do they compare? Nuwellis Inc trades at $0.69 (market cap $2.20M), while Quantum Computing Inc trades at $7.53 (market cap $1.69B). The key difference: Quantum Computing Inc is far larger — about 768.2× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (121,544 versus 7,991,522). Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Quantum Computing Inc for 25 Days on average.
| NUWE | QUBT | |
|---|---|---|
Market Cap | $2.20M | $1.69B |
Volume | 121,544 | 7,991,522 |
Sector | Health | Technology |
52-Week High | $146.65 | $21.78 |
52-Week Low | $0.68 | $6.31 |
Typical Hold Time | 26 Days | 25 Days |
Enterprise Value | -$1.52M | $753.24M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Quantum Computing Inc. (QUBT) trades at $7.62, down 3.05% today, with a bearish technical signal despite bullish oscillators. The company shows explosive revenue growth from $682K in 2025 to $10M in 2026 but remains deeply unprofitable with a -152.45% net income margin. Recent developments include the Dirac-3S quantum system announcement and a $42.5M backlog, though rising expenses and cash burn persist.
Analysts maintain a bullish consensus with a $17.33 price target (75% buy ratings), seeing potential in QUBT's quantum technology expansion. However, significant execution risks, continued losses, and high valuation (P/S 157.36) create substantial downside potential if commercialization timelines slip or funding needs increase.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Quantum Computing Inc
Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →
